Mechanisms of Norovirus Pathogenesis and Replication to Develop Therapeutics

诺如病毒发病机制和复制机制以开发治疗方法

• 批准号: 10674942
• 负责人: Robert L. Atmar
• 金额: $ 217.45万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-12-01 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10674942
• 关键词: Acute; Address; Antibodies; Antibody Response; Antiviral Agents; Basic Science; Biological Assay; Biology; Biosensor; Cell Culture System; Cells; Chemistry; Clinical; Collaborations; Complement; Cryoelectron Microscopy; Crystallography; Data; Development; Disease; Economics; Electron Microscopy; Epitopes; Evaluation; Funding; Gastroenteritis; Goals; Health; Human; Immunity; In Vitro; Infection; Infection prevention; Intestines; Knowledge; Mediating; Microscopy; Modeling; Molecular; Norovirus; Pathogenesis; Peptide Hydrolases; Persons; Pharmaceutical Preparations; Polymerase; Population; Populations at Risk; Prevention strategy; Proteins; Public Health; RNA-Directed RNA Polymerase; Receptor Cell; Recording of previous events; Regimen; Reproducibility; Research; Research Design; Research Personnel; Role; Services; Site-Directed Mutagenesis; Structure; Symptoms; Synthesis Chemistry; System; Talents; Testing; Therapeutic; United States; Vaccines; Viral; Viral Antibodies; Viral Pathogenesis; Viral Physiology; Viral Proteins; Virus; Virus Replication; Virus-like particle; antiviral drug development; biophysical techniques; combat; cross reactivity; design; effective therapy; experience; helicase; human stem cells; improved; inhibitor; insight; neutralizing antibody; novel; pathogen; permissiveness; programs; prospective; protein purification; receptor; response; skills; small molecule; success; therapeutically effective; treatment strategy; virus host interaction

Mechanisms of Norovirus Pathogenesis and Replication to Develop Therapeutics Project Summary Noroviruses are the most common cause of gastroenteritis in the United States, and they cause a significant economic and health burden to the population. A significant barrier to progress in making effective therapeutics, antivirals and vaccines to control human norovirus illness was the previous lack of a cell culture system. The focus of this program project is to build upon previous basic science and translational findings and discoveries to allow continued progress in our understanding of the biology and pathogenesis of these viruses so that improved control strategies can be developed. We recently developed a successful replication system that discovered strain- specific requirements for replication and allows neutralization assays and antivirals to be tested. We will pursue key questions on virus pathogenesis and cellular responses, structure-function studies on the interactions between virus proteins and host components, discover key factors that restrict extensive propagation and test antivirals and neutralizing antibodies in three separate projects. In Project 1 we will perform studies designed to provide us with a fundamental molecular understanding of how human noroviruses cause disease, and of what epitopes are recognized by human sera that are associated with virus neutralization, virus clearance, and protective immunity. In addition, we will build on recent success and continue to develop antivirals for treatment and prevention strategies that can be applied to at risk populations. In Project 2 we will continue to improve the cultivation system, focusing on identifying the cell receptor(s) and understanding why all HuNoV strains do not grow in the replication system. We will also evaluate molecular mechanisms by which norovirus replication regulates cellular innate responses and whether these cellular responses regulate viral replication and spread. In Project 3 we will determine the structural basis for novel functions of key proteins that regulate viral replication and virus-host interactions to provide a rational framework for the development of antivirals. These projects will be supported by three cores. Core A (Administrative Core) will provide centralized administrative and fiscal management support and will coordinate programmatic activities. Core B (the Microscopy and Enteroid Core) will provide expertise and services to each project related to electron microscopy and fluorescent microscopy. This core will also maintain and provide enteroids, including genetically-modified cultures and biosensor lines to all projects. Core C (the Protein and Small Molecule Chemistry Core) will provide all projects with access to purified proteins and virus-like particles as well as facilitating site-directed mutagenesis activities needed. In addition, the Core will synthesize small molecules to be used for protease and polymerase inhibition studies in each project. The program project brings together a highly collaborative group of investigators with diverse skills and talents, and an substantial history of working together. As in the previous funding period, the interactions among each project and each of the cores will be extensive and synergistic such that the activities of each project will be enhanced considerably over what could be accomplished if the projects were pursued independently.

诺如病毒的致病和复制机制以开发治疗药物 项目摘要 诺如病毒是美国胃肠炎最常见的原因，它们会引起显著的 给人民带来经济和健康负担。这是制造有效治疗方法的一个重大障碍， 控制人类诺如病毒疾病的抗病毒药物和疫苗是以前缺乏细胞培养系统。重点 该计划项目的目的是建立在以前的基础科学和转化发现和发现， 我们对这些病毒的生物学和发病机理的理解不断取得进展， 可以制定控制策略。我们最近开发了一个成功的复制系统，发现了菌株- 复制的特定要求，并允许中和试验和抗病毒药进行测试。我们会继续追查 关于病毒发病机制和细胞反应的问题， 病毒蛋白和宿主成分，发现限制广泛传播的关键因素，并测试抗病毒药物 和中和抗体的研究在项目1中，我们将进行旨在提供 我们对人类诺如病毒如何引起疾病以及哪些表位有了基本的分子理解， 被人血清识别，与病毒中和、病毒清除和保护性作用有关。 免疫力此外，我们将在最近成功的基础上继续开发用于治疗和预防的抗病毒药物 可应用于高危人群的策略。在项目2中，我们将继续改进栽培系统， 专注于识别细胞受体并理解为什么所有HuNoV毒株在复制中不生长 系统我们还将评估诺如病毒复制调节细胞先天免疫的分子机制。 以及这些细胞反应是否调节病毒复制和传播。在项目3中， 确定调节病毒复制和病毒宿主的关键蛋白质的新功能的结构基础 相互作用，为抗病毒药物的开发提供合理的框架。这些项目将得到支持 三个核心。核心A（行政核心）将提供集中的行政和财政管理 支持并协调方案活动。核心B（显微镜检查和肠样核心）将提供 为每个与电子显微镜和荧光显微镜有关的项目提供专业知识和服务。核心将 还维护和提供肠，包括转基因培养和生物传感器线的所有项目。 核心C（蛋白质和小分子化学核心）将为所有项目提供纯化蛋白质 和病毒样颗粒以及促进所需的定点诱变活性。此外，核心将 合成小分子，用于每个项目中的蛋白酶和聚合酶抑制研究。程序 该项目汇集了一群具有不同技能和才能的高度协作的调查人员， 一起工作的历史。与上一个供资期一样， 每个核心都将是广泛和协同的，这样每个项目的活动都将得到加强 如果这些项目独立进行，所能取得的成就将大不相同。

项目成果

Clinical and In Vitro Evidence Favoring Immunoglobulin Treatment of a Chronic Norovirus Infection in a Patient With Common Variable Immunodeficiency.

• DOI: 10.1093/infdis/jiac085
• 发表时间: 2022-11-11
• 期刊: The Journal of infectious diseases

Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells.

• DOI: 10.3201/eid1903.121029
• 发表时间: 2013-03
• 期刊: Emerging infectious diseases
• 影响因子: 11.8
• 作者: Herbst-Kralovetz MM;Radtke AL;Lay MK;Hjelm BE;Bolick AN;Sarker SS;Atmar RL;Kingsley DH;Arntzen CJ;Estes MK;Nickerson CA
• 通讯作者: Nickerson CA

Norovirus infection as a cause of sporadic healthcare-associated diarrhoea.

诺如病毒感染是导致散发性医疗相关腹泻的原因。

• DOI: 10.1016/j.jhin.2009.03.010
• 发表时间: 2009
• 期刊: The Journal of hospital infection
• 作者: Koo,HL;Ajami,NJ;Jiang,Z-D;Atmar,RL;DuPont,HL
• 通讯作者: DuPont,HL

Secretory pathway antagonism by calicivirus homologues of Norwalk virus nonstructural protein p22 is restricted to noroviruses.

• DOI: 10.1186/1743-422x-9-181
• 发表时间: 2012-09-03
• 期刊: Virology journal
• 影响因子: 4.8
• 作者: Sharp TM;Crawford SE;Ajami NJ;Neill FH;Atmar RL;Katayama K;Utama B;Estes MK
• 通讯作者: Estes MK

Norovirus contamination on French marketed oysters.

• DOI: 10.1016/j.ijfoodmicro.2013.07.022
• 发表时间: 2013-09-02
• 期刊: International journal of food microbiology
• 影响因子: 5.4
• 作者: Schaeffer J;Le Saux JC;Lora M;Atmar RL;Le Guyader FS
• 通讯作者: Le Guyader FS